506 related articles for article (PubMed ID: 12139181)
1. Staphylococcus aureus resistant to vancomycin--United States, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):565-7. PubMed ID: 12139181
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant Staphylococcus aureus--New York, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(15):322-3. PubMed ID: 15103297
[TBL] [Abstract][Full Text] [Related]
3. Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Sep; 46(35):813-5. PubMed ID: 9310213
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.
Fridkin SK; Hageman J; McDougal LK; Mohammed J; Jarvis WR; Perl TM; Tenover FC;
Clin Infect Dis; 2003 Feb; 36(4):429-39. PubMed ID: 12567300
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 48(51-52):1165-7. PubMed ID: 11266244
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Oct; 51(40):902. PubMed ID: 12418544
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.
Sievert DM; Rudrik JT; Patel JB; McDonald LC; Wilkins MJ; Hageman JC
Clin Infect Dis; 2008 Mar; 46(5):668-74. PubMed ID: 18257700
[TBL] [Abstract][Full Text] [Related]
9. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
Appelbaum PC
Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
McDonald LC; Hageman JC
Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
[TBL] [Abstract][Full Text] [Related]
11. From the Centers for Disease Control. Staphylococcus aureus resistant to vancomycin--United States, 2002.
JAMA; 2002 Aug; 288(7):824-5. PubMed ID: 12194166
[No Abstract] [Full Text] [Related]
12. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
Fridkin SK
Clin Infect Dis; 2001 Jan; 32(1):108-15. PubMed ID: 11118389
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus with reduced susceptibility to vancomycin.
Cosgrove SE; Carroll KC; Perl TM
Clin Infect Dis; 2004 Aug; 39(4):539-45. PubMed ID: 15356818
[TBL] [Abstract][Full Text] [Related]
15. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
[TBL] [Abstract][Full Text] [Related]
16. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Appelbaum PC
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a vancomycin intermediate-resistant Staphylococcus aureus isolated from a hospital.
Mirani ZA; Jamil N
J Coll Physicians Surg Pak; 2010 Aug; 20(8):558-9. PubMed ID: 20688028
[TBL] [Abstract][Full Text] [Related]
18. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(27):624-6. PubMed ID: 9218648
[TBL] [Abstract][Full Text] [Related]
19. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran.
Aligholi M; Emaneini M; Jabalameli F; Shahsavan S; Dabiri H; Sedaght H
Med Princ Pract; 2008; 17(5):432-4. PubMed ID: 18685289
[TBL] [Abstract][Full Text] [Related]
20. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK; Sen MR
BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
